ADMA Stock Summary and Trading Ideas (Adma Biologics | NASDAQ:ADMA)

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

What symbol and exchange does Adma Biologics shares trade?

Adma Biologics trades on the NASDAQ stock market under the symbol ADMA.

What is Adma Biologics stock price doing today?

As of December 16, 2025, ADMA stock price climbed to $19.76 with 34,826 million shares trading.

What is Adma Biologics's Beta?

ADMA has a beta of 0.28, meaning it tends to be less sensitive to market movements. ADMA has a correlation of 0.01 to the broad based SPY ETF.

How much is Adma Biologics worth?

ADMA has a market cap of $4.70 billion. This is considered a Mid Cap stock.

How much money does Adma Biologics make?

Last quarter Adma Biologics reported $134 million in Revenue and $.16 earnings per share. This beat revenue expectation by $4 million and met earnings estimates .

What is the highest and lowest price Adma Biologics traded in the last 3 year period?

In the last 3 years, ADMA traded as high as $25.67 and as low as $2.95.

What are the top ETFs holding Adma Biologics?

The top ETF exchange traded funds that ADMA belongs to (by Net Assets): IJR, VTI, IWM, XBI, VB.

Is Adma Biologics (ADMA) a good investment?

ADMA has underperformed the market in the last year with a return of +6.3%, while SPY returned +13.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ADMA shares. However, ADMA has outperformed the market in the last 3 month and 2 week periods, returning +29.2% and +2.0%, while SPY returned +3.1% and -0.1%, respectively. This indicates ADMA has been having a stronger performance recently.

What are the support and resistance levels for Adma Biologics (ADMA)?

ADMA support price is $19.16 and resistance is $20.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADMA shares will trade within this expected range on the day.